Diadema Partners »

Nextcure shares owned by Diadema Partners

Quarter-by-quarter ownership of Nextcure (NXTC) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Nextcure

Tip: Access up to 7 years of quarterly data

All positions including Nextcure held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nextcure by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $12k 7.7k 1.60

More positions owned by Diadema Partners

Abivax Sa Sponsored Ads Call Option (ABVX)
Viking Therapeutics (VKTX)
Bristol Myers Squibb Put Option (BMY)
Amgen Call Option (AMGN)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Uniqure Nv SHS Put Option (QURE)
Novartis Sponsored Adr Call Option (NVS)
Kodiak Sciences Call Option (KOD)
Capricor Therapeutics Com New Put Option (CAPR)
Cogent Biosciences (COGT)
Bridgebio Pharma Note 1.750% 3/0 (Principal)
Corcept Therapeutics Incorporated Call Option (CORT)
BioMarin Pharmaceutical (BMRN)
Kymera Therapeutics Call Option (KYMR)

View all positions for Diadema Partners

Top funds holding Nextcure

Ikarian Capital
Adage Capital Partners GP
Sofinnova Ventures
Renaissance Technologies
Vanguard Capital Management
Millennium Management
Boothbay Fund Management
Squadron Capital Management
Verdad Advisers
Pfizer
Affinity Asset Advisors
BlackRock
Hrt Financial
Jane Street
Geode Capital Management

View all funds holding Nextcure